These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2787650)

  • 1. Tumor immunotherapy.
    Manson LA
    Immunol Today; 1989 Feb; 10(2):36. PubMed ID: 2787650
    [No Abstract]   [Full Text] [Related]  

  • 2. T cells and tumors.
    Maas RA; Dullens HF; Den Otter W
    Immunol Today; 1992 Feb; 13(2):78-9. PubMed ID: 1575895
    [No Abstract]   [Full Text] [Related]  

  • 3. Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy.
    Finn OJ
    Important Adv Oncol; 1992; ():61-77. PubMed ID: 1374733
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotherapy of malignant disease.
    Wright PW; Bernstein ID
    Prog Exp Tumor Res; 1980; 25():140-62. PubMed ID: 6986629
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular engineering of the antitumor immune response.
    Pardoll DM; Golumbek P; Levitsky H; Jaffee L
    Bone Marrow Transplant; 1992; 9 Suppl 1():182-6. PubMed ID: 1387016
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular tumor-associated antigens represent effective targets for passive immunotherapy.
    Noguchi T; Kato T; Wang L; Maeda Y; Ikeda H; Sato E; Knuth A; Gnjatic S; Ritter G; Sakaguchi S; Old LJ; Shiku H; Nishikawa H
    Cancer Res; 2012 Apr; 72(7):1672-82. PubMed ID: 22318866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of antibody in tumor immunity.
    Economou JS
    Surg Gynecol Obstet; 1981 Sep; 153(3):417-31. PubMed ID: 7268622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta).
    Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H
    J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
    Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
    Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted cellular immunotherapy with bifunctional antibodies.
    Nelson H
    Cancer Cells; 1991 May; 3(5):163-72. PubMed ID: 1832553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
    Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
    [No Abstract]   [Full Text] [Related]  

  • 13. T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes.
    Melief CJ; Kast WM
    Immunol Rev; 1995 Jun; 145():167-77. PubMed ID: 7590825
    [No Abstract]   [Full Text] [Related]  

  • 14. Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activity.
    Shimizu Y; Hasumi K; Masubuchi K; Okudaira Y
    Eur J Immunol; 1988 Nov; 18(11):1773-8. PubMed ID: 2974424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms.
    Melief CJ; Kast WM
    Semin Cancer Biol; 1991 Oct; 2(5):347-54. PubMed ID: 1773050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes].
    Kan N; Hori T; Ohgaki K; Inamoto T; Kodama H; Tobe T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1298-306. PubMed ID: 3488027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Different immunological factors in the therapy of an experimental tumor].
    Nicolin A; Frontini E; Olivani P
    Boll Ist Sieroter Milan; 1971; 50(4):295-8. PubMed ID: 5163498
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutagen-induced antigenic variants of tumor cells.
    Boon T; Van Pel A; De Plaen E; Vessière F
    Symp Fundam Cancer Res; 1986; 38():139-48. PubMed ID: 3489258
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tumor-specific immunotherapy: active immunotherapy by augmenting the induction of tumor-specific effector T cells through a T-T cell interaction mechanism].
    Kosugi A; Fujiwara H; Hamaoka T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1527-35. PubMed ID: 6236750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gordian knot of tumour immunology.
    Amlot P
    Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.